pedics entistry Osteoarthritis Therapy

CERASORB® Dentistry.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4–32 Orthopedics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33–40 Scientific Fundamentals. . . . . . . . . . . . . . . . . . ....

Scientific Fundamentals Preclinic / in-vitro and in-vivo study Material Scientific / Fundamental Research

Lerner H (2017): Augmentation and defect filling in oral surgery. A multicenter non-interventional study. implants 2017, 2: 26-30. Comment: CERASORB® Paste, membranes, Osgide®, PTFE “The novel paste-like bone regeneration material CERASORB® Paste, based on small P-TCP granules and a hyaluronic acid matrix has proven its efficacy in the filling of smaller jaw defects under daily practice conditions, especially because of its good manageability.” d Alveolenmanagement - Vorgehen und Mehrwert fur Praxis und Foam Patient. [Teethridge Management - Approach and Benefit for Practice and Patient.] Dent...

2015 DC Lorenz J, Barbeck M, Schlee M, Lerner H, Teiler A, Sader R, CERASORB® d Ghanaati S (2015): Anwendungsbeobachtung einer p-TCP- Paste basierten Knochenersatzmaterialpaste. [Observation Study of a bone substitute paste based on p-TCP.] Implantologie Journal 2015: 6: 24-30. Article in German. Comment: “When placing dental implants three months after augmentation a bony regenerated implant site was found, which enabled a stable insertion of dental implants.”

CERASORB® - 2013 Year Legend Literature Harel N, Moses O, Palti A, Ormianer Z (2013): Long-term results of implants immediately placed into extraction sockets grafted with p-tricalcium phosphate: A retrospective study. J Oral Maxillofac Surg 2013, 71 (2): e63-e68. Comment: “In a 10 year retrospective study the crestal bone loss around immediate implant placed in tricalcium phosphate [TCP] grafted extraction sockets was evaluated. The use of TCP [CERASORB®] as a grafting material during immediate implant placement allowed no bone loss in 72.1% of the implants, which was very similar to the nongrafted...

d Evaluation of CERASORB® M as a bone graft used for sinus lift and dental implant installation. Abstract No. O10.12 in: Abstracts of the 19th International Conference on Oral and Maxillofacial Surgery, Shanghai, China, 23-27 May, 2009. International Journal of Oral and Maxillofacial Surgery, May 2009, 38 (5): S. 499 von 397-608. Comment: “The X-ray revealed complete or nearly complete degradation of the beta-tricalcium phosphate granules with concurrent bone substitution in the majority of cases in 12 months post grafting. The implants showed good stability 12 months after installation.”

DENTISTRY Year 2009 DC Harnack L, Boedeker RH, Kurtulus I, Boehm S, Gonzales J, CERASORB®, Use of platelet-rich plasma in periodontal surgery - a prospective randomised double blind clinical trial. Clin Oral Investig. 2009 Jun; 13 (2): 179-187. “22 patients showing contralateral intrabony defects were treated with p-TCP CERASORB® alone or in combination with PRP. p-TCP is a satisfactory graft material in periodontal surgery, even without PRP.” CERASORB®, barriers, membranes, PTFE Comment: 2009 DC Horowitz RA, Mazor Z, Miller RJ, Krauser J, Prasad HS, Rohrer Clinical evaluation of alveolar...

Nitsch A, Gruber R, Daevers INC, Patyk A, Merten HA (2009): Sinusbodenaugmentation mit β-Tricalciumphosphat und plättchenreichem Plasma. [Sinus floor elevation with β-tricalcium phosphate and Platelet Rich Plasma.] ZWR 2009, 118 (6): 276–287. Article in German. Comment: “In 29 patients an augmentation of sinus maxillaris with β-TCP or β-TCP and PRP was performed. The histomorphologic findings showed a progredient hydrolytic β-TCP degradation and cellular resorption of the ceramic fragments. The addition of PRP showed no difference.” 2009 Waluga R (2009): Erfolgsbewertung der klinischen Anwendung...

CERASORB® - 2008 Year Legend Literature 2008 DC Knabe C, Koch C, Rack A, Stiller M (2008): d Effect of beta-tricalcium phosphate particles with varying porosity on osteogenesis after sinus floor augmentation in humans. Biomaterials 2008, 29: 2249-2258. Comment: “2 groups of 10 patients each were treated with CERASORB® and CERASORB® M. After 6 months, bone formation and matrix mineralization were still actively progressing in the tissue surrounding the particles. In the CERASORB® M-group, bone formation and particle degradation had already reached a more advanced stage.” 2008 DC Plenk...

d A New Bioresorbable Membrane in Augmentation Surgery. PRP, Comment: “A new bioresorbable membrane (INION) in combination with CERASORB® M and PRP enables the placement of implants after sinus augmentation, even in cases where the residual bone hight was to be considered borderline for single-stage procedure.”

CERASORB® - 2006Year Legend Literature Products 2006 DC Bilk D (2006): d Eine neue resorbierbare Membran. [A New Resorbable Membrane.] Implantologie Journal 2006, 1: 22-24. Article in German. Comment: “The augmentation was performed with a combination of CERASORB® M, fresh blood and PRP covered by the resorbable membrane INION. This procedure leads to good bone regeneration after 6 months.” 2006 DC Cseplo K, Vaszilko M, Bogdan S, Barabas J, Suba Z, Szabo G Use of p-tricalcium-phosphate (CERASORB®) to fill large jawbone defects: a medium-term study. Poster presentation, XV. ALACIBU-Congress...